期刊文献+

后TRIPS时代药品获得权与其专利权的冲突与协调 被引量:2

Conflict and Coordination of Right to Access to Medicines and Patent Right of Medicines after TRIPS Era
下载PDF
导出
摘要 药品获得权是一项由生命权、健康权派生而来的人权,是指人为了维护其生命和健康而享有的获得药品的权利。《与贸易有关的知识产权协定》(TRIPS)是当前对知识产权设定最低保护标准的多边贸易协定,它所确认的药品专利权对药品获得权存在负面影响,二者存在冲突。我们应基于法益优先保护原则和利益平衡原则协调二者的冲突。WTO为此已积极做出了努力,但冲突仍在,因此,必须不断寻求新的协调之法。 The right to access to medicines is one of human rights, deriving from right of life and right to health TRIPS is a multilateral trade agreement which give intellectual property lowest protection level. Patent right of med icines has negative influence on the right to access to medicines. Coordination is necessary for tackling the conflic tion. WTO has taken some measures but the confliction is still existing. So, new way should be find.
作者 李琴
出处 《现代财经(天津财经大学学报)》 CSSCI 北大核心 2008年第5期85-89,共5页 Modern Finance and Economics:Journal of Tianjin University of Finance and Economics
基金 湖南省教育厅科学研究项目"多边贸易体制与人权保护法律问题研究"(07C837) 中南林业科技大学青年科学基金项目"环境贸易措施和多边贸易体制研究"(07QY025)
关键词 TRIPS 药品获得权 药品专利权 人权 TRIPS Right to Access to Medicines Patent Right of Medicines Human Rights
  • 相关文献

参考文献12

  • 1刘俊敏,王秀玲.TRIPs协议下药品专利保护与公共健康的冲突与协调[J].学术论坛,2006,29(8):157-161. 被引量:8
  • 2张爱宁.国际人权法专论[M].北京:法律出版社,2002.
  • 3General Comment No. 6 of CCPR(1982), Para. 4.
  • 4Committee on Economic, Social and Cultural Rights. The right to the highest attainable standard of health. 11/08/2000. E/. 12/2000/4, CESCR General Comment 14, para 17.
  • 5E/C. 12/2000/4. (General Comments)
  • 6Thomas Pogge, Sunil Shaunak. The human right to access essential medicines[EB/OL], www. theRSA, org,2007-8-20.
  • 7吴汉东.知识产权VS人权:冲突、交叉与协调[N].中国知识产权报,2004-01-06.
  • 8E.博登海默.邓正来译..法理学、法律哲学与法律方法[M]..北京:中国政法大学出版社,,1999....
  • 9The impact of trade-related intellectual property rights on access to affordable medicines and human rights[EB/OL]. www. 3 dthree, org, 2007 - 8- 20.
  • 10鄢琳,周杰明,井春梅,肖爱丽,张承绪.世界卫生组织基本药物示范目录:挑战与发展[J].中国药物警戒,2006,3(5):261-266. 被引量:10

二级参考文献14

  • 1周俊强.与公共健康危机有关的知识产权国际保护[J].中国法学,2005(1):111-118. 被引量:19
  • 2[1]WHO.Revised procedure for updating WHO's Model List of Essenial Drugs[G].EB109/8.Geneva:World Health Organization,2001.
  • 3[2]WHO.Access to Essential Medicines as a Global Necessity 25th Anniversary of the WHO Model List of Essential Medicines[EB/OL].[2006-05-20].http://www.who.int/dg/speeches/2002/ whoessentialmedicines/en/print.html.
  • 4[3]Laing R,Waning B,Gray A,et al.25 years of the WHO essential medicines lists:progress and challenges[J].The Lancet-Vol.361,Issue 9370,17 May 2003,Pages 1723-1729.
  • 5[4]WHO.WHO Policy Perspectives on Medicines-The Selection of Essential Medicines[G].Geneva:World Health Organization,2002.
  • 6[5]WHO.How to Develop and implement a national drug policy[G].Geneva:World Health Organization,2001.
  • 7[6]WHO.Technical Report Series WHO no 914[G].Geneva:World Health Organization,2003.
  • 8[7]WHO/EDM Department of Essential Drugs and Medicines Policy.Updating and disseminating the WHO Model List of Essential Drugs:the way forward[G].Geneva:World Health Organization,2001.
  • 9[8]WHO.Technical Report Series WHO no 920[G].Geneva:World Health Organization,2004.
  • 10[9]WHO.Website for Declaration of Interests for WHO Experts[EB/OL].[2006-05-20].http://mednet3.who.int/EML/expcom/ expcom14/expertcomm14.html.

共引文献21

同被引文献24

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部